SARS-CoV-2: Is the liver merely a bystander to severe disease?

doi:10.1016/j.jhep.2020.05.035

Comment

. 2020 Oct;73(4):995-996.

doi: 10.1016/j.jhep.2020.05.035. Epub 2020 Jun 2.

SARS-CoV-2: Is the liver merely a bystander to severe disease?

Mansoor N Bangash¹, Jaimin M Patel², Dhruv Parekh², Nicholas Murphy², Rachel M Brown³, Ahmed M Elsharkawy⁴, Gautam Mehta⁵, Matthew J Armstrong⁴, Desley Neil³

Affiliations

¹ Liver Intensive Care Unit, Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Birmingham, UK; Birmingham Liver Failure Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK. Electronic address: mansoor.bangash@uhb.nhs.uk.
² Liver Intensive Care Unit, Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Birmingham, UK; Birmingham Liver Failure Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK.
³ Birmingham Liver Failure Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK; Department of Cellular Pathology, QEHB, Mindelsohn Way, Birmingham, UK; Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK.
⁴ Birmingham Liver Failure Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK; Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK; Liver Unit, Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Birmingham, UK.
⁵ Institute for Liver and Digestive Health, Royal Free Campus, UCL, London, UK; Institute of Hepatology, Foundation for Liver Research, London, UK.

PMID: 32502510
PMCID: PMC7265856
DOI: 10.1016/j.jhep.2020.05.035

Comment

SARS-CoV-2: Is the liver merely a bystander to severe disease?

Mansoor N Bangash et al. J Hepatol. 2020 Oct.

. 2020 Oct;73(4):995-996.

doi: 10.1016/j.jhep.2020.05.035. Epub 2020 Jun 2.

Authors

Mansoor N Bangash¹, Jaimin M Patel², Dhruv Parekh², Nicholas Murphy², Rachel M Brown³, Ahmed M Elsharkawy⁴, Gautam Mehta⁵, Matthew J Armstrong⁴, Desley Neil³

Affiliations

¹ Liver Intensive Care Unit, Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Birmingham, UK; Birmingham Liver Failure Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK. Electronic address: mansoor.bangash@uhb.nhs.uk.
² Liver Intensive Care Unit, Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Birmingham, UK; Birmingham Liver Failure Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK.
³ Birmingham Liver Failure Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK; Department of Cellular Pathology, QEHB, Mindelsohn Way, Birmingham, UK; Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK.
⁴ Birmingham Liver Failure Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK; Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK; Liver Unit, Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Birmingham, UK.
⁵ Institute for Liver and Digestive Health, Royal Free Campus, UCL, London, UK; Institute of Hepatology, Foundation for Liver Research, London, UK.

PMID: 32502510
PMCID: PMC7265856
DOI: 10.1016/j.jhep.2020.05.035

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest Dr. Armstrong reports personal fees from Novo Nordisk, outside the submitted work. All other authors have no conflicts of interest to declare. Please refer to the accompanying ICMJE disclosure forms for further details.

Comment in

Reply to: Correspondence relating to "SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19".
Wang Y, Lu F, Zhao J. Wang Y, et al. J Hepatol. 2020 Oct;73(4):996-998. doi: 10.1016/j.jhep.2020.06.028. Epub 2020 Jun 23. J Hepatol. 2020. PMID: 32589896 Free PMC article. No abstract available.

Comment on

SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
Wang Y, Liu S, Liu H, Li W, Lin F, Jiang L, Li X, Xu P, Zhang L, Zhao L, Cao Y, Kang J, Yang J, Li L, Liu X, Li Y, Nie R, Mu J, Lu F, Zhao S, Lu J, Zhao J. Wang Y, et al. J Hepatol. 2020 Oct;73(4):807-816. doi: 10.1016/j.jhep.2020.05.002. Epub 2020 May 11. J Hepatol. 2020. PMID: 32437830 Free PMC article.

Cited by

Risk of Death in Comorbidity Subgroups of Hospitalized COVID-19 Patients Inferred by Routine Laboratory Markers of Systemic Inflammation on Admission: A Retrospective Study.
Cocoş R, Mahler B, Turcu-Stiolica A, Stoichiță A, Ghinet A, Shelby ES, Bohîlțea LC. Cocoş R, et al. Viruses. 2022 May 31;14(6):1201. doi: 10.3390/v14061201. Viruses. 2022. PMID: 35746672 Free PMC article.
Clinical and Histopathological Discoveries in Patients with Hepatic Injury and Cholangiopathy Who Have Died of COVID-19: Insights and Opportunities for Intervention.
Lim JK, Njei B. Lim JK, et al. Hepat Med. 2023 Oct 4;15:151-164. doi: 10.2147/HMER.S385133. eCollection 2023. Hepat Med. 2023. PMID: 37814605 Free PMC article. Review.
Prevalence and Prognostic Impact of Deranged Liver Blood Tests in COVID-19: Experience from the Regional COVID-19 Center over the Cohort of 3812 Hospitalized Patients.
Paštrovic F, Lucijanic M, Atic A, Stojic J, Barisic Jaman M, Tjesic Drinkovic I, Zelenika M, Milosevic M, Medic B, Loncar J, Mijic M, Filipec Kanizaj T, Kralj D, Lerotic I, Virovic Jukic L, Ljubicic N, Luetic K, Grgic D, Majerovic M, Ostojic R, Krznaric Z, Luksic I, Piskac Zivkovic N, Keres T, Grabovac V, Persec J, Barsic B, Grgurevic I. Paštrovic F, et al. J Clin Med. 2021 Sep 17;10(18):4222. doi: 10.3390/jcm10184222. J Clin Med. 2021. PMID: 34575333 Free PMC article.
COVID-19 and the liver: Are footprints still there?
Gupta T, Sharma H. Gupta T, et al. World J Gastroenterol. 2023 Jan 28;29(4):656-669. doi: 10.3748/wjg.v29.i4.656. World J Gastroenterol. 2023. PMID: 36742164 Free PMC article. Review.
Percutaneous microwave ablation applications for liver tumors: recommendations for COVID-19 patients.
Afaghi P, Lapolla MA, Ghandi K. Afaghi P, et al. Heliyon. 2021 Mar 6;7(3):e06454. doi: 10.1016/j.heliyon.2021.e06454. eCollection 2021 Mar. Heliyon. 2021. PMID: 33748501 Free PMC article. Review.

See all "Cited by" articles

References

1. Wang Y., Liu S., Liu H., Li W., Lin F., Jiang L. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J Hepatol. 2020;72(4):807–816. - PMC - PubMed
1. Bangash M.N., Patel J., Parekh D. COVID-19 and the liver: little cause for concern. Lancet Gastroenterol Hepatol. 2020;5(6):529–530. - PMC - PubMed
1. Li W., Deng M., Loughran P.A., Yang M., Lin M., Yang C. LPS induces active HMGB1 release from hepatocytes into exosomes through the coordinated activities of TLR4 and caspase-11/GSDMD signaling. Front Immunol. 2020;11:229. - PMC - PubMed
1. Grasl-Kraupp B., Ruttkay-Nedecky B., Koudelka H., Bukowska K., Bursch W., Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology. 1995;21(5):1465–1468. - PubMed
1. Miller S.E., Brealey J.K. Visualization of putative coronavirus in kidney. Kidney Int. 2020;98(1):231–232. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Miscellaneous
- NCI CPTAC Assay Portal

[1] Wang Y., Liu S., Liu H., Li W., Lin F., Jiang L. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J Hepatol. 2020;72(4):807–816. - PMC - PubMed

[2] Wang Y., Liu S., Liu H., Li W., Lin F., Jiang L. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J Hepatol. 2020;72(4):807–816. - PMC - PubMed

[3] Bangash M.N., Patel J., Parekh D. COVID-19 and the liver: little cause for concern. Lancet Gastroenterol Hepatol. 2020;5(6):529–530. - PMC - PubMed

[4] Bangash M.N., Patel J., Parekh D. COVID-19 and the liver: little cause for concern. Lancet Gastroenterol Hepatol. 2020;5(6):529–530. - PMC - PubMed

[5] Li W., Deng M., Loughran P.A., Yang M., Lin M., Yang C. LPS induces active HMGB1 release from hepatocytes into exosomes through the coordinated activities of TLR4 and caspase-11/GSDMD signaling. Front Immunol. 2020;11:229. - PMC - PubMed

[6] Li W., Deng M., Loughran P.A., Yang M., Lin M., Yang C. LPS induces active HMGB1 release from hepatocytes into exosomes through the coordinated activities of TLR4 and caspase-11/GSDMD signaling. Front Immunol. 2020;11:229. - PMC - PubMed

[7] Grasl-Kraupp B., Ruttkay-Nedecky B., Koudelka H., Bukowska K., Bursch W., Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology. 1995;21(5):1465–1468. - PubMed

[8] Grasl-Kraupp B., Ruttkay-Nedecky B., Koudelka H., Bukowska K., Bursch W., Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology. 1995;21(5):1465–1468. - PubMed

[9] Miller S.E., Brealey J.K. Visualization of putative coronavirus in kidney. Kidney Int. 2020;98(1):231–232. - PMC - PubMed

[10] Miller S.E., Brealey J.K. Visualization of putative coronavirus in kidney. Kidney Int. 2020;98(1):231–232. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

SARS-CoV-2: Is the liver merely a bystander to severe disease?

Affiliations

SARS-CoV-2: Is the liver merely a bystander to severe disease?

Authors

Affiliations

Conflict of interest statement

Comment in

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Miscellaneous